Confronto
Dulaglutide vs. Pemvidutide
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Metabolico
Metabolico
N. CAS
923950-08-7
nessun dato
Peso molecolare
59670 g/mol
nessun dato
Emivita
110 h
nessun dato
Sequenza
GLP-1(7-37)-Variante kovalent verbunden mit modifiziertem humanen IgG4-Fcnessun dato
Meccanismo d'azione
Dulaglutide
Dulaglutide consists of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc. The Fc fusion increases molecular weight substantially (~60 kDa), reduces renal filtration and extends the half-life to several days. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon, delays gastric emptying and modulates central satiety signalling.
Pemvidutide
The GLP-1 component suppresses appetite while the glucagon component raises energy expenditure and acts directly on hepatic fat metabolism — the combination is intended to mimic the complementary effects of diet and exercise.
Base di evidenze
Evidenza più alta
RCT sull'uomo
Studio sull'uomo
Studi
5
1
di cui sull'uomo
5
1
Effetti registrati
3
2
Contraddizioni aperte
1
0
Eventi avversi documentati
2
1
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Dulaglutide and Pemvidutide?
- Dulaglutide is classified as "Metabolico", while Pemvidutide is classified as "Metabolico". Dulaglutide: GLP-1 receptor agonist designed as a fusion protein of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc fragment. FDA-approved 2014 (Trulicity) for type 2 diabetes; EMA approval 2014. Pemvidutide: Pemvidutide is a 29-amino-acid GLP-1/glucagon dual receptor agonist (Altimmune) under investigation for obesity and the fatty-liver disease MASH. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Dulaglutide or Pemvidutide?
- The highest available evidence level is "RCT sull'uomo" for Dulaglutide and "Studio sull'uomo" for Pemvidutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Dulaglutide and Pemvidutide in Germany and the United States?
- Germania: Dulaglutide — Su prescrizione, Pemvidutide — Non approvato. Stati Uniti: Dulaglutide — Su prescrizione, Pemvidutide — Non approvato. These are factual summaries with source and review date on the individual pages.